Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk factors for Alzheimer’s disease
Richard A. Armstrong
Folia Neuropathologica (2019) Vol. 57, Iss. 2, pp. 87-105
Open Access | Times Cited: 468

Showing 1-25 of 468 citing articles:

Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
Zeinab Breijyeh, Rafik Karaman
Molecules (2020) Vol. 25, Iss. 24, pp. 5789-5789
Open Access | Times Cited: 1858
Western diet as a trigger of Alzheimer’s disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration
Angelika Więckowska‐Gacek, Anna Mietelska‐Porowska, Małgorzata Wydrych, et al.
Ageing Research Reviews (2021) Vol. 70, pp. 101397-101397
Open Access | Times Cited: 242
Therapies for Prevention and Treatment of Alzheimer’s Disease
Jesus Mendiola-Precoma, Laura C. Berumen, Karla Padilla, et al.
BioMed Research International (2016) Vol. 2016, pp. 1-17
Open Access | Times Cited: 225
Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
C. Kwon Kim, Yin Rui Lee, Lynnett Ong, et al.
Journal of Alzheimer s Disease (2022) Vol. 87, Iss. 1, pp. 83-100
Open Access | Times Cited: 126
The Role of Diet as a Modulator of the Inflammatory Process in the Neurological Diseases
Antonina Kurowska, Wojciech Ziemichód, Mariola Herbet, et al.
Nutrients (2023) Vol. 15, Iss. 6, pp. 1436-1436
Open Access | Times Cited: 68
Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β
Anne‐Cathrine S. Vogt, Gary T. Jennings, Mona O. Mohsen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3895-3895
Open Access | Times Cited: 52
An Insight into Cellular and Molecular Mechanisms Underlying the Pathogenesis of Neurodegeneration in Alzheimer’s Disease
Yashumati Ratan, Aishwarya Rajput, Sushmita Maleysm, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1398-1398
Open Access | Times Cited: 50
Oxidative Stress and Bio-Regulation
Toshikazu Yoshikawa, Fukka You
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3360-3360
Open Access | Times Cited: 30
Unraveling the therapeutic efficacy of resveratrol in Alzheimer’s disease: an umbrella review of systematic evidence
Ali Azargoonjahromi, Fatemeh Abutalebian
Nutrition & Metabolism (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting
Xuemei Zeng, Yijun Chen, Anuradha Sehrawat, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 17
Prediction of Alzheimer's disease progression within 6 years using speech: A novel approach leveraging language models
Samad Amini, Boran Hao, Jingmei Yang, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5262-5270
Open Access | Times Cited: 17
Chronic RNA G-quadruplex accumulation in aging and Alzheimer’s disease
Lena Kallweit, Eric D. Hamlett, Hannah Saternos, et al.
eLife (2025) Vol. 14
Open Access | Times Cited: 3
A New Role for RNA G-quadruplexes in Aging and Alzheimer’s Disease
Lena Kallweit, Eric D. Hamlett, Hannah Saternos, et al.
eLife (2025) Vol. 14
Open Access | Times Cited: 2
Exercise, APOE genotype, and the evolution of the human lifespan
David A. Raichlen, Gene E. Alexander
Trends in Neurosciences (2014) Vol. 37, Iss. 5, pp. 247-255
Open Access | Times Cited: 113
Association between chronic stress and Alzheimer’s disease: Therapeutic effects of Saffron
Mohammad Saeedi, Ali Rashidy‐Pour
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110995-110995
Open Access | Times Cited: 95
Cholinergic Modulation of Glial Function During Aging and Chronic Neuroinflammation
Rashmi Gamage, Ingrid Wagnon, Ilaria Rossetti, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 93
What causes neurodegenerative disease?
Richard A. Armstrong
Folia Neuropathologica (2020) Vol. 58, Iss. 2, pp. 93-112
Open Access | Times Cited: 86
PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases
Anthony Cunha, Alexandra Gaubert, Laurent Latxague, et al.
Pharmaceutics (2021) Vol. 13, Iss. 7, pp. 1042-1042
Open Access | Times Cited: 80
Diet quality, gut microbiota, and microRNAs associated with mild cognitive impairment in middle-aged and elderly Chinese population
Xiaona Zhang, Yushan Wang, Wen Liu, et al.
American Journal of Clinical Nutrition (2021) Vol. 114, Iss. 2, pp. 429-440
Open Access | Times Cited: 77
Analysis the Link between Periodontal Diseases and Alzheimer’s Disease: A Systematic Review
Leslie Borsa, Margaux Dubois, Guillaume Sacco, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 17, pp. 9312-9312
Open Access | Times Cited: 75
Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders
Аnna Morozova, Yana Zorkina, Olga Abramova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1217-1217
Open Access | Times Cited: 70
Astrocytes as a Therapeutic Target in Alzheimer’s Disease–Comprehensive Review and Recent Developments
Mateo Rodríguez-Giraldo, Rodrigo E. González-Reyes, Sofía Ramírez-Guerrero, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13630-13630
Open Access | Times Cited: 64
Recent Advances in the Treatment of Alzheimer’s Disease Using Nanoparticle-Based Drug Delivery Systems
Prashant Poudel, Soyeun Park
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 835-835
Open Access | Times Cited: 63
Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases
Thomas McGrath, Richard Baskerville, Marcelo Macedo Rogero, et al.
Nutrients (2022) Vol. 14, Iss. 5, pp. 917-917
Open Access | Times Cited: 58
Role of Chemokines in the Development and Progression of Alzheimer’s Disease
Jakub Wojcieszak, K Kuçzyńska, Jolanta B. Zawilska
Journal of Molecular Neuroscience (2022) Vol. 72, Iss. 9, pp. 1929-1951
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top